皖维高新(600063) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥2,498,063,275.38, representing a 46.96% increase compared to the same period last year [5] - The net profit attributable to shareholders was ¥415,215,000.85, showing a significant increase of 221.92% year-on-year [5] - The net profit after deducting non-recurring gains and losses was ¥426,298,554.07, reflecting a 242.51% increase compared to the previous year [5] - Basic and diluted earnings per share were both ¥0.216, an increase of 222.39% compared to the same period last year [5] - Net profit for Q1 2022 was ¥415,201,436.05, compared to ¥128,974,464.59 in Q1 2021, representing a significant increase of 223.0% [28] - Earnings per share for Q1 2022 were ¥0.216, up from ¥0.067 in Q1 2021, indicating strong growth in profitability [30] - The total comprehensive income for Q1 2022 was ¥359,766,696.50, compared to ¥2,986,435.03 in Q1 2021, showing a substantial improvement [30] Cash Flow - The net cash flow from operating activities reached ¥531,977,719.87, marking a substantial increase of 1,025.68% year-on-year [5] - In Q1 2022, the cash inflow from operating activities was approximately $2.30 billion, a significant increase from$1.59 billion in Q1 2021, representing a growth of about 44.7% [35] - The net cash flow from operating activities reached approximately $532 million, compared to only$47 million in the same period last year, indicating a substantial improvement [37] - Cash inflow from investment activities totaled approximately $66.16 million, up from$16.03 million in Q1 2021, marking an increase of about 313.5% [36] - The net cash flow from investment activities was negative at approximately -$272.12 million, an improvement from -$405.98 million in Q1 2021 [37] - Cash inflow from financing activities was approximately $1.18 billion, slightly down from$1.28 billion in Q1 2021, reflecting a decrease of about 7.7% [37] - The net cash flow from financing activities was negative at approximately -$24.23 million, contrasting with a positive cash flow of$367.72 million in the same quarter last year [37] - The total cash and cash equivalents at the end of Q1 2022 amounted to approximately $348.46 million, an increase from$208.75 million at the end of Q1 2021, representing a growth of about 67% [37] - The company received approximately $900 million in borrowings during Q1 2022, down from$1.10 billion in Q1 2021, indicating a decrease of about 18.5% [37] - The cash received from tax refunds was approximately $74.07 million, significantly higher than$22.34 million in Q1 2021, showing an increase of about 231.5% [35] - The cash paid to employees increased to approximately $174.38 million from$133.87 million in Q1 2021, reflecting a rise of about 30.4% [35] Assets and Liabilities - Total assets at the end of the reporting period were ¥12,309,768,397.11, a 5.63% increase from the end of the previous year [8] - Total current liabilities amounted to CNY 4,882,375,768.35, up from CNY 4,514,147,039.91, indicating a rise of around 8.1% [23] - The total liabilities increased to ¥5,590,281,008.50 in Q1 2022 from ¥5,296,121,789.70 in Q1 2021, reflecting a rise of 5.5% [28] - Total equity attributable to shareholders rose to ¥6,687,598,141.63 in Q1 2022, compared to ¥6,326,012,900.38 in Q1 2021, marking an increase of 5.7% [28] - Total current assets reached CNY 5,483,418,485.90, compared to CNY 4,856,866,390.43 at the end of 2021, reflecting an increase of approximately 12.9% [19] - The total non-current liabilities decreased to ¥707,905,240.15 in Q1 2022 from ¥781,974,749.79 in Q1 2021, reflecting a reduction of 9.5% [28] Shareholder Information - The company reported a total of 107,812 common shareholders at the end of the reporting period [14] - The largest shareholder, Anhui Wanwei Group Co., Ltd., holds 30.74% of the shares, totaling 591,965,118 shares [14] - The company has not disclosed any related party relationships or concerted actions among the top shareholders [16] Research and Development - The company reported a significant increase in research and development expenses by 76.31% due to increased investment in R&D activities [10] - Research and development expenses for Q1 2022 were ¥113,056,748.11, up 76.4% from ¥64,123,395.70 in Q1 2021, highlighting increased investment in innovation [28] Other Information - The company does not have any significant new product or technology developments reported in this quarter [16] - The company experienced an 82.53% increase in accounts receivable, primarily due to increased export amounts and letters of credit [10] - The company’s cash flow from investing activities increased by ¥133,862,500, mainly due to a decrease in cash paid for investments compared to the same period last year [10] - Accounts receivable increased significantly to CNY 513,027,610.26 from CNY 281,062,080.16, reflecting an increase of approximately 82.4% [19] - Short-term borrowings increased to CNY 1,926,009,833.33 from CNY 1,830,009,625.00, which is an increase of about 5.2% [23]